NorthStar Asset Management (Pennsylvania)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $449K | Sell |
2,065
-50
| -2% | -$11.1K | 0.1% | 97 |
|
|
2025
Q4 | $483K | Hold |
2,115
| – | – | 0.1% | 94 |
|
|
2025
Q3 | $490K | Hold |
2,115
| – | – | 0.11% | 92 |
|
|
2025
Q2 | $393K | Sell |
2,115
-25
| -1% | -$4.65K | 0.09% | 115 |
|
|
2025
Q1 | $448K | Hold |
2,140
| – | – | 0.11% | 98 |
|
|
2024
Q4 | $380K | Hold |
2,140
| – | – | 0.09% | 112 |
|
|
2024
Q3 | $423K | Hold |
2,140
| – | – | 0.1% | 102 |
|
|
2024
Q2 | $367K | Sell |
2,140
-235
| -10% | -$38.9K | 0.09% | 109 |
|
|
2024
Q1 | $432K | Hold |
2,375
| – | – | 0.11% | 103 |
|
|
2023
Q4 | $368K | Hold |
2,375
| – | – | 0.1% | 108 |
|
|
2023
Q3 | $354K | Buy |
2,375
+200
| +9% | +$29.4K | 0.1% | 105 |
|
|
2023
Q2 | $293K | Buy |
2,175
+10
| +0.5% | +$1.47K | 0.08% | 118 |
|
|
2023
Q1 | $345K | Buy |
2,165
+15
| +0.7% | +$2.29K | 0.1% | 108 |
|
|
2022
Q4 | $347K | Hold |
2,150
| – | – | 0.11% | 108 |
|
|
2022
Q3 | $289K | Hold |
2,150
| – | – | 0.1% | 115 |
|
|
2022
Q2 | $329K | Hold |
2,150
| – | – | 0.1% | 109 |
|
|
2022
Q1 | $349K | Hold |
2,150
| – | – | 0.09% | 111 |
|
|
2021
Q4 | $291K | Hold |
2,150
| – | – | 0.07% | 128 |
|
|
2021
Q3 | $232K | Hold |
2,150
| – | – | 0.06% | 135 |
|
|
2021
Q2 | $242K | Buy |
2,150
+4
| +0.2% | +$450 | 0.06% | 134 |
|
|
2021
Q1 | $232K | Sell |
2,146
-255
| -11% | -$27.3K | 0.07% | 126 |
|
|
2020
Q4 | $257K | Buy |
+2,401
| New | +$231K | 0.07% | 120 |
|
|
2020
Q3 | – | Sell |
-2,376
| Closed | -$233K | – | 126 |
|
|
2020
Q2 | $233K | Buy |
+2,376
| New | +$209K | 0.08% | 113 |
|
|
2020
Q1 | – | Sell |
-2,622
| Closed | -$232K | – | 113 |
|
|
2019
Q4 | $232K | Buy |
+2,622
| New | +$218K | 0.09% | 113 |
|
|
2019
Q2 | – | Sell |
-2,628
| Closed | -$212K | – | 121 |
|
|
2019
Q1 | $212K | Sell |
2,628
-100
| -4% | -$8.18K | 0.09% | 113 |
|
|
2018
Q4 | $251K | Hold |
2,728
| – | – | 0.12% | 95 |
|
|
2018
Q3 | $258K | Buy |
2,728
+30
| +1% | +$2.85K | 0.1% | 105 |
|
|
2018
Q2 | $250K | Buy |
2,698
+70
| +3% | +$6.84K | 0.1% | 100 |
|
|
2018
Q1 | $249K | Hold |
2,628
| – | – | 0.1% | 99 |
|
|
2017
Q4 | $254K | Hold |
2,628
| – | – | 0.11% | 95 |
|
|
2017
Q3 | $234K | Buy |
+2,628
| New | +$200K | 0.1% | 96 |
|
|
2017
Q1 | – | Sell |
-4,428
| Closed | -$277K | – | 116 |
|
|
2016
Q4 | $277K | Hold |
4,428
| – | – | 0.13% | 101 |
|
|
2016
Q3 | $279K | Hold |
4,428
| – | – | 0.12% | 99 |
|
|
2016
Q2 | $274K | Hold |
4,428
| – | – | 0.11% | 97 |
|
|
2016
Q1 | $253K | Hold |
4,428
| – | – | 0.11% | 99 |
|
|
2015
Q4 | $262K | Buy |
4,428
+500
| +13% | +$28.8K | 0.11% | 96 |
|
|
2015
Q3 | $214K | Hold |
3,928
| – | – | 0.1% | 99 |
|
|
2015
Q2 | $264K | Sell |
3,928
-200
| -5% | -$13.1K | 0.11% | 92 |
|
|
2015
Q1 | $242K | Sell |
4,128
-700
| -14% | -$42.3K | 0.1% | 93 |
|
|
2014
Q4 | $316K | Hold |
4,828
| – | – | 0.14% | 88 |
|
|
2014
Q3 | $279K | Hold |
4,828
| – | – | 0.12% | 92 |
|
|
2014
Q2 | $272K | Hold |
4,828
| – | – | 0.12% | 93 |
|
|
2014
Q1 | $248K | Buy |
4,828
+500
| +12% | +$25.3K | 0.11% | 89 |
|
|
2013
Q4 | $229K | Buy |
+4,328
| New | +$213K | 0.11% | 84 |
|
Other funds holding ABBV
VCM
VPM
NorthStar Asset Management (Pennsylvania)'s ABBV Position: Q1 2026 in Review
NorthStar Asset Management (Pennsylvania) reduced its AbbVie (ABBV) stake by 2.4% in Q1 2026, selling an estimated $11.1K and leaving 2,065 shares worth $449K. The position accounts for 0.1% of the portfolio, ranked #97.
NorthStar Asset Management (Pennsylvania) first reported a position in ABBV in Q4 2013 and has held it in 44 quarters since. The position peaked at $490K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- NorthStar Asset Management (Pennsylvania) held 2,065 shares of AbbVie worth $449K as of Q1 2026.
- NorthStar Asset Management (Pennsylvania) sold 50 AbbVie shares in Q1 2026, an estimated $11.1K.
- AbbVie made up 0.1% of NorthStar Asset Management (Pennsylvania)'s portfolio in Q1 2026, its #97 holding.
- NorthStar Asset Management (Pennsylvania) first reported a position in AbbVie in Q4 2013 and has held it in 44 quarters since.
- NorthStar Asset Management (Pennsylvania)'s AbbVie position peaked at $490K in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q1 2026, filed 23 Apr 2026.